This is a high impact position with great visibility across all levels of the Alkermes organization. The primary role is to drive Alkermes's clinical development portfolio in neurology.

Specifically, this position will have critical hands-on leadership responsibilities in the clinical department involved in the development of therapies for neurology indications, including neurodegenerative and sleep disorders. The Executive Director will drive the strategies and clinical development plans across all phases of drug development. Key domains include development of study protocols, medical review of clinical trial data and generation of clinical study reports. The Executive Director will interact externally with key global regulatory authorities, industry and scientific organizations, as well as external key thought leaders. This position will work cross-functionally to ensure projects are coordinated with partners from multiple departments within Alkermes including regulatory, preclinical pharmacology and toxicology, CMC, new product planning, project management, patient engagement, health economics, legal, finance, medical affairs and commercial.PDN-9a955afd-e0cb-4b0e-8eae-7e1db6f7c3e1